Kaplan Myron 4
4 · CorMedix Inc. · Filed Oct 27, 2025
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Kaplan Myron
Director
Transactions
- Purchase
Common Stock
2025-10-23$11.02/sh+25,000$275,500→ 201,034 total
Holdings
- 10,000(indirect: By Spouse)
Common Stock
- 20,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.01 to $11.03, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.